In this context, Bond et al. have identified a SNP in the p53-sensitive P2-promoter of the MDM2 gene – designated as SNP309 – which affects the risk of developing cancer [20] in a gender-specific and hormone-dependent manner [21]. This evidence concerns the gene MDM2 and cancer.